Efforts towards erasing borders in gynecologic cancer?

Abstract

HighlightsCervical cancer is the second most common cancer among women in LMIC.Major efforts to improve research in gynecologic cancer in LMIC are needed.GOR provides a platform featuring research and review of cancer care in LMIC.

Cervical cancer screening and treatment capacity: A survey of members of the African Organisation for Research and Training in Cancer (AORTIC)

“…In 2020, there were 604,127 cervical cancer cases and 341,831 deaths worldwide, and 84% of all new cases and 88% of all deaths occur in low- and middle- income countries (LMIC) Chuang et al, 2017 , International Agency for Research on Cancer, 2020 . Although screening and comprehensive treatment are widely available in the United States, Canada, Western Europe, Australia, New Zealand, and many Pacific rim countries, LMIC face unique challenges in providing women with screening and treatment for cervical cancer.…”

Barriers to cervical cancer screening and acceptability of HPV self-testing: a cross-sectional comparison between ethnic groups in Southern Thailand

“…In particular, studies have shown that the use of primary HPV testing, as compared with cytology alone, significantly lowers the likelihood of the development of precancerous lesions among women undergoing cervical cancer screening, due to increased sensitivity and specificity of cytology testing when restricted to only those women who test positive for HPV 16. In addition, some countries are beginning to implement self-collection HPV testing to increase accessibility to screening 17. Women can test themselves, in their own home, by collecting a cervical sample using a provided swab 18.…”